{"nct_id":"NCT01711736","title":"Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2012-11-01","start_date_type":"ACTUAL","primary_completion_date":"2013-02-21","primary_completion_date_type":"ACTUAL","completion_date":"2013-06-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}